stage prostate cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group
Sitenames

Male only (1)

Phase 2 (1)

Interventional (1)

Radboud University (1)

No (1)

No (1)

Adult (18+) (1)

amsterdam (1)
antoni (1)
cancer (1)
center (1)
groningen (1)
institut (1)
leeuwenhoek (1)
medic (1)
netherland (1)
radboud (1)
umc (1)
univers (1)
van (1)

I am/have/had

I am/have/hadadenocarcinoma of prostate

I am/have/hadcastration-sensitive prostate cancer

I am/have/hadpet/ct scan

I am/have/hadadenocarcinoma

I am/have/hadmetastasis

I am/have/hadwhite blood cell count

I am/have/hadprostate cancer metastatic

I am/have/hadplatelet count

I am/have/hadmetastatic prostate cancer

added new label for I am/have/had

more

I am looking for

I am looking forapalutamide

I am looking foradjuvant

I am looking forbicalutamide

I am looking forfinasteride

I am looking forhormone therapy

I am looking fortaxane

I am looking forabiraterone

I am looking forimmunological adjuvant

I am looking forcabazitaxel

I am looking fordocetaxel

I am looking forenzalutamide

I am looking fordutasteride

I am looking fortestosterone

I am looking forendocrine therapy

I am looking forandrogens

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Males
Family Medicine
Recruiting

Lutetium-177-PSMA-I&T in Oligo-metastatic Hormone Sensitive Prostate Cancer

Radioligand therapy (RLT) using Lutetium-177 labelled PSMA is a promising new therapeutic approach to treat metastatic prostate cancer. This tumor-specific treatment is directed against prostate-specific membrane antigen (PSMA), which is overexpressed in prostate cancer cells. In the last few years, several lutetium-177 (177Lu, emitter) labeled PSMA ligands have been …

apalutamide

adjuvant

immunological adjuvant

pet/ct scan

metastasis

4 views
22 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.